Taiwan: More flexibility on post-grant amendments

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: More flexibility on post-grant amendments

According to Article 67 of the Patent Law, post-grant amendments are permissible only if they are conducted to (1) delete claims; (2) restrict the scope of claims; (3) correct misstatements and mistranslations; or (4) clarify uncertainties. In general, such post-grant amendments shall not go beyond the disclosure of the specification, claims and drawings as originally filed. Nor shall they substantially broaden or alter the scope of the claims.

Recently, Taiwan's IP Office has relaxed the guideline on determining what constitutes substantial alteration to granted claims. Under the old guideline, only when a post-grant amendment was to amend the granted claims by adding additional features which are in a strict and narrow genus-species relationship with at least one of the original granted claims would it be accepted. Starting January 1 2017, a post-grant claim amendment shall not be regarded as having introduced substantial alteration provided that the original object of the claimed invention remains achievable.

In view of the relaxation of the examination guideline, a patent owner's request to amend granted claims by including additional features may become allowable. To be more specific, adding a technical feature of an embodiment disclosed in the original specification into a granted claim, an amendment hardly permissible in the past is now possible so long as the same invention object can still be achieved. For instance, for a granted claim reciting the features of a pedal of a wheelchair, it is now acceptable to add the features relating to a swivel table disclosed in the specification as originally filed as a limitation to the said claim since the addition does not alter the object of the claimed invention.

A post-grant amendment shall be acceptable if it does not in any way alter or impair the original object of the claimed invention. In order that patent owners seeking post-grant amendments can make better preparations, it is worth observing how examiners will put into practice the new guideline during examination.

wu.jpg

Jun-yan Wu


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

Two partners have departed DLA Piper to join Squire Patton Boggs and Blank Rome in San Francisco and Chicago, respectively
Practitioners say a 32% rise in court fees is somewhat expected to maintain the UPC’s strong start, but some warn that SME clients could be squeezed out
Swati Sharma and Revanta Mathur at Cyril Amarchand Mangaldas explain how they overcame IP office objections to secure victory for a tyre manufacturer
Claudiu Feraru, founder of Feraru IP, discusses the benefits of a varied IP practice and why junior practitioners should learn from every case
In the ninth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP & ME, a community focused on ethnic minority IP professionals
Firms that made strategic PTAB hires say that insider expertise is becoming more valuable in the wake of USPTO changes
Aled Richards-Jones, a litigator and qualified barrister, is the fourth partner to join the firm’s growing patent litigation team this year
An IP lawyer tasked with helping to develop Brownstein’s newly unveiled New York office is eyeing a measured approach to talent hunting
Amanda Griffiths, who will be tasked with expanding the firm’s trademark offering in New Zealand, says she hopes to offer greater flexibility to clients at her new home
News of EasyGroup failing in its trademark infringement claim against ‘Easihire’ and Amgen winning a key appeal at the UPC were also among the top talking points
Gift this article